author-photo

Naomi Elster

Royal College of Surgeons in Ireland

6

Papers

107

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Frequency, impact and a preclinical study of novel ERBB gene family mutations in HER2-positive breast cancer:

2018 Therapeutic Advances in Medical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

2017 Oncotarget
Show All
- Source
- Cite
- Save
Citations (10)
The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (7)
Effect of somatic mutations in the four genes of the HER family on occurrence in HER2-positive breast cancer, cell proliferation rates, and resistance to HER2-targeted therapies in vitro.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinib

2015 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (33)